Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

78
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
78

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Subtypes of Cholangiocarcinoma and their Translational Implications.

Gastroenterology·2026
Same author

Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies eight risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21.

HGG advances·2026
Same author

SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis.

NPJ precision oncology·2026
Same author

Lower Allele Frequency of <i>TERT</i>-rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk.

JCO global oncology·2026
Same author

Real-World Analysis of Multidisciplinary Roles in the Management of Hepatocellular Carcinoma: The Mayo Clinic Experience.

Journal of hepatocellular carcinoma·2026

Related Experiment Video

Updated: Jun 6, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Surveillance for Hepatocellular Carcinoma.

Lewis R Roberts1

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, 200 First Street Southwest, Rochester, MN 55905, USA.

Clinics in Liver Disease
|November 28, 2024
PubMed
Summary

Effective hepatocellular carcinoma (liver cancer) surveillance is crucial for early detection and improved patient outcomes. This review covers optimal screening strategies, risk stratification, and future improvements for better cancer control.

Keywords:
Cancer controlEarly detectionScreeningSurveillanceSurvival

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

385

Related Experiment Videos

Last Updated: Jun 6, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

385

Area of Science:

  • Hepatology
  • Oncology
  • Public Health

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern, often diagnosed at late stages.
  • Early detection through surveillance is critical for improving patient survival rates and treatment efficacy.
  • Current surveillance strategies require optimization for broader impact and better patient outcomes.

Purpose of the Study:

  • To review current practices and future directions in hepatocellular carcinoma surveillance.
  • To identify optimal methods for selecting individuals for surveillance and screening frequency.
  • To explore strategies for overcoming barriers and enhancing the effectiveness of surveillance programs.

Main Methods:

  • Comprehensive literature review of surveillance for early-stage hepatocellular carcinoma.
  • Analysis of rationale, selection criteria, screening methods, and frequency.
  • Discussion of strategies to address surveillance barriers and emerging technologies.

Main Results:

  • Surveillance is vital for early HCC detection, leading to improved patient outcomes.
  • Optimal selection of at-risk individuals and appropriate screening methods are key.
  • Emerging technologies can enhance risk stratification, cost-effectiveness, and accessibility.

Conclusions:

  • Integrating liver cancer surveillance into national public health programs is essential.
  • Future improvements in surveillance technologies and strategies will enhance cancer control.
  • Enhanced surveillance leads to more effective treatment and better patient survival.